The DOI matches its OpenAlex record; 40 of the 40 references it cites were found in a registry or an index.
T cell homeostatic proliferation elicits effective antitumor autoimmunity
Open accessAbstract
Development of tumor immunotherapies focuses on inducing autoimmune responses against tumor-associated self-antigens primarily encoded by normal, unmutated genes. We hypothesized that such responses could be elicited by T cell homeostatic proliferation in the periphery, involving expansion of T cells recognizing self-MHC/peptide ligands. Herein, we demonstrate that sublethally irradiated lymphopenic mice transfused with autologous or syngeneic T cells showed tumor growth inhibition when challenged with melanoma or colon carcinoma cells. Importantly, the antitumor response depended on homeostatic expansion of a polyclonal T cell population within lymph nodes. This response was effective even for established tumors, was characterized by CD8(+) T cell-mediated tumor-specific cytotoxicity and IFN-gamma production, and was associated with long-term memory. The results indicate that concomitant induction of the physiologic processes of homeostatic T cell proliferation and tumor antigen presentation in lymph nodes triggers a beneficial antitumor autoimmune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin
De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., et al. (1994) · Science · doi:10.1126/science.8171322 · Cited by 986
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
Selecting and maintaining a diverse T-cell repertoire
Goldrath, A. W., & Bevan, M. J. (1999) · Nature · doi:10.1038/35005508 · Cited by 714
The role of CD4+ T cell responses in antitumor immunity
Pardoll, D. M., & Topalian, S. L. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80228-8 · Cited by 672
Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo
Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A., & Rudensky, A. (2002) · Nature Immunology · doi:10.1038/ni743 · Cited by 640
Cho, B. K., Rao, V. P., Ge, Q., Eisen, H. N., & Chen, J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.549 · Cited by 509
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
Ochsenbein, A. F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H., & Zinkernagel, R. M. (2001) · Nature · doi:10.1038/35082583 · Cited by 493
Cutting Edge: Naive T Cells Masquerading as Memory Cells
Murali-Krishna, K., & Ahmed, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1733 · Cited by 462
Banks, T. A., Rouse, B. T., Kerley, M. K., Blair, P. J., Godfrey, V. L., Kuklin, N. A., Bouley, D. M., Thomas, J., Kanangat, S., & Mucenski, M. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.1685 · Cited by 440
Cancer antigens: immune recognition of self and altered self.
Houghton, A. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.1 · Cited by 420
Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C.-C., Carroll, M. W., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2982 · Cited by 381
Dendritic cells: On the move from bench to bedside
Nestle, F. O., Banchereau, J., & Hart, D. (2001) · Nature Medicine · doi:10.1038/89863 · Cited by 287
Yewdell, J. W., Norbury, C. C., & Bennink, J. R. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60785-3 · Cited by 284
Boon, T., & Old, L. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80049-0 · Cited by 283
Homeostatic T Cell Proliferation
Surh, C. D., & Sprent, J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.f9 · Cited by 277
Homeostasis of αβ TCR+ T cells
Marrack, P., Bender, J., Hildeman, D., Jordan, M., Mitchell, T., Murakami, M., Sakamoto, A., Schaefer, B. C., Swanson, B., & Kappler, J. (2000) · Nature Immunology · doi:10.1038/77778 · Cited by 245
Haraguchi, M., Yamashiro, S., Yamamoto, A., Furukawa, K., Takamiya, K., Lloyd, K. O., Shiku, H., & Furukawa, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10455 · Cited by 215
Restoration of T-cell homeostasis after T-cell depletion
Mackall, C. L., Hakim, F. T., & Gress, R. E. (1997) · Seminars in Immunology · doi:10.1006/smim.1997.0091 · Cited by 210
Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone
Udaka, K., Wiesmüller, K. H., Kienle, S., Jung, G., & Walden, P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.670 · Cited by 196
Induction of anti-self-immunity to cure cancer
Nanda, N. K., & Sercarz, E. E. (1995) · Cell · doi:10.1016/0092-8674(95)90047-0 · Cited by 196
Immunity against cancer: lessons learned from melanoma
Houghton, A. N., Gold, J. S., & Blachere, N. E. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00195-3 · Cited by 190
Inducing autoimmune disease to treat cancer
Pardoll, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5340 · Cited by 183
Cutting Edge: CD4+ T Cell Control of CD8+ T Cell Reactivity to a Model Tumor Antigen
Surman, D. R., Dudley, M. E., Overwijk, W. W., & Restifo, N. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.562 · Cited by 172
Asavaroengchai, W., Kotera, Y., & Mulé, J. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022634999 · Cited by 169
Autologous Regulation of Naive T Cell Homeostasis Within the T Cell Compartment
Dummer, W., Ernst, B., LeRoy, E., Lee, D., & Surh, C. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2460 · Cited by 164
Self-citationMice transgenic for human carcinoembryonic antigen as a model for immunotherapy.
Clarke, P., Mann, J. R., Simpson, J. F., Rickard-Dickson, K. J., & Primus, F. J. (1998) · PubMed · Cited by 148
Oehen, S., & Brduscha‐Riem, K. (1999) · European Journal of Immunology · Cited by 140
T cell homeostasis and systemic autoimmunity
Theofilopoulos, A. N., Dummer, W., & Kono, D. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12173 · Cited by 133
Self-citationGe, Q., Rao, V. P., Cho, B. K., Eisen, H. N., & Chen, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1728 · Cited by 132
Corazza, N., Eichenberger, S., Eugster, H., & Mueller, C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1479 · Cited by 123
Multiple Paths for Activation of Naive CD8+ T Cells: CD4-Independent Help
Wang, B., Norbury, C. C., Greenwood, R., Bennink, J. R., Yewdell, J. W., & Frelinger, J. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1283 · Cited by 102
The risk of autoimmunity associated with tumor immunotherapy
Gilboa, E. (2001) · Nature Immunology · doi:10.1038/ni0901-789 · Cited by 84
Autoimmunity and the Immunotherapy of Cancer: Targeting the "Self" to Destroy the "Other"
Overwijk, W. W., & Restifo, N. P. (2000) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v20.i6.10 · Cited by 83
Epitope affinity for MHC class I determines helper requirement for CTL priming
Franco, A., Tilly, D. A., Gramaglia, I., Croft, M., Cipolla, L., Meldal, M., & Grey, H. M. (2000) · Nature Immunology · doi:10.1038/77827 · Cited by 76
Therapeutic Vaccination for Cancer
Pardoll, D. M. (2000) · Clinical Immunology · doi:10.1006/clim.1999.4819 · Cited by 76
L-selectin and β7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes
Wagner, N., Löhler, J., Tedder, T. F., Rajewsky, K., Müller, W., & Steeber, D. A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3832::aid-immu3832>3.0.co;2-j · Cited by 75
Self-citationDendritic cells and tumor immunity
Gunzer, M., Jänich, S., Varga, G., & Grabbe, S. (2001) · Seminars in Immunology · doi:10.1006/smim.2001.0325 · Cited by 69
MHC-II-Independent CD4+ T Cells Induce Colitis in Immunodeficient RAG−/− Hosts
Trobonjača, Z., Leithäuser, F., Möller, P., Bluethmann, H., Koezuka, Y., MacDonald, H. R., & Reimann, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3804 · Cited by 39
Cited by
Miller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A., & Dudley, M. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2355 · Cited by 1,659
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Gattinoni, L., Finkelstein, S. E., Klebanoff, C. A., Antony, P. A., Palmer, D. C., Spiess, P. J., Hwang, L. N., Yu, Z., Wrzesinski, C., Heimann, D. M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050732 · Cited by 1,061
Antony, P. A., Piccirillo, C. A., Akpinarli, A., Finkelstein, S. E., Speiss, P. J., Surman, D. R., Palmer, D. C., Chan, C.-C., Klebanoff, C. A., Overwijk, W. W., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2591 · Cited by 760
Metadata
- Authors
- Dummer, W., Niethammer, A. G., Baccalà, R., Lawson, B. R., Wagner, N., Reisfeld, R. A., & Theofilopoulos, A. N.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2002-07-15
- Volume
- 110
- Issue
- 2
- Pages
- 185-192
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1976823049
- Cited by
- 308
- References
- 40
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.